Protagonist Therapeutics Inc (NASDAQ:PTGX)

17.30
BATS BZX Real-Time Price
As of 3:08pm ET
 +1.84 / +11.90%
Today’s Change
12.80
Today|||52-Week Range
50.54
-14.19%
Year-to-Date
Protagonist Therapeutics (PTGX) Moves 18.2% Higher: Will This Strength Last?
Sep 22 / Zacks.com - Paid Partner Content
Why Protagonist Therapeutics Stock Is Tanking Today
Sep 17 / MotleyFool.com - Paid Partner Content
Why Protagonist Therapeutics Stock Plunged Today
Sep 20 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close15.46
Today’s open15.62
Day’s range15.51 - 17.35
Volume113,184
Average volume (3 months)792,821
Market cap$828.8M
Data as of 3:08pm ET, 09/23/2021

Growth & Valuation

Earnings growth (last year)+35.48%
Earnings growth (this year)-31.32%
Earnings growth (next 5 years)--
Revenue growth (last year)+12,293.07%
P/E ratioNM
Price/Sales24.22
Price/Book2.73

Competitors

 Today’s
change
Today’s
% change
CRISCuris Inc+0.06+0.79%
DTILPrecision BioScience...+0.49+3.84%
ANABAnaptysBio Inc-0.19-0.67%
MRSNMersana Therapeutics...+0.09+0.94%
Data as of 3:08pm ET, 09/23/2021

Financials

Next reporting dateNovember 10, 2021
EPS forecast (this quarter)-$0.67
Annual revenue (last year)$28.6M
Annual profit (last year)-$66.2M
Net profit margin-231.07%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Newark, California

Forecasts